The Therapeutic Goods Administration (TGA) has provisionally approved the use of the Pfizer Covid-19 vaccine in individuals 12 years and older.
Previously, the Pfizer Covid-19 vaccine was provisionally approved for use in individuals 16 years or older.
The TGA says that provisional approval for use in the 12-15 years age group has been made following careful evaluation of the available data supporting safety and efficacy, including clinical studies with adolescents 12 to 15 years of age.
Use in this age group was supported by the independent expert Advisory Committee on Vaccines.
